News & Events

Platinum leads immuno-oncology company HaemaLogiX’s $10m round

12 September 2021

HaemaLogiX raises $10 million to advance multiple myeloma treatments

8 September 2021

HaemaLogiX announces collaboration with the Peter MacCallum Cancer Centre

5 February 2021

Orphan Drug Designation for KappaMab transferred to HaemaLogiX

29 January 2021

HaemaLogiX announces issuance of Australian patent for LMA

22 January 2021

HaemaLogiX Announces the Outcomes of Two Innovation Connections Grant Projects

16 October 2020

Bryce Carmine to present at AusBiotech & Invest 2020

9 October 2020

HaemaLogiX announces results of collaboration with CellVec

2 October 2020

HaemaLogiX announces issuance of Australian patent for KMA.CAR

25 September 2020

Prof Andrew Spencer presents KappaMab Phase 2b interim analysis results at ASH 2019

8 December 2019

HaemaLogiX initiates collaboration with Universidad de Navarra

5 November 2019

HaemaLogiX initiates collaboration with TPL Path Labs

7 May 2019